PT-141 and Melanotan insufficient for finasteride-induced sexual dysfunction
Dr. Bachmeyer warns that men who develop post-finasteride syndrome (PFS) — permanent impotence in 35% of PFS cases — should not expect PT-141 (bremelanotide) or melanotan to restore function. He argues these peptides cannot overcome the underlying biological damage caused by finasteride because the root biology has been permanently altered.